濮阳东方看妇科病收费便宜(濮阳市东方医院治病怎么样) (今日更新中)

BAIKONUR, Kazakhstan, April 5 (Xinhua) -- Russian manned spacecraft Soyuz TMA-21 has been transported to the launch pad and raised to a vertical position, ready to blast off on April 5, Xinhua correspondents reported Saturday from the site.The launch is dedicated to the 50th anniversary of the first flight into space in 1961 carried out by Russian cosmonaut Yuri Gagarin.For hours, journalists and tourists from all over the world had braved a nasty weather and watched the train and trucks delivering the rocket to the pad.Service towers move towards the Soyuz TMA-21 spacecraft, named after the first cosmonaut Yuri Gagarin, as it is set on its launch pad at Baikonur cosmodrome April 2, 2011. The International Space Station (ISS) crew of U.S. astronaut Ronald Garan and crew mates Russian cosmonauts Alexandr Samokutyaev and Andrey Borisenko is due to travel by Soyuz spacecraft to the ISS on April 5.The Soyuz TMA-21 rocket will deliver three crew members to the International Space Station (ISS) on April 5. In a six-month mission, these cosmonauts will carry out over 40 experiments.The Soyuz TMA modification is a replacement of the Soyuz TM as it was equipped with smaller and more efficient computers and improved displays. The Soyuz TMA-21 will also serve as the return vehicle of the ISS crew.

BEIJING, Jan. 30 (Xinhua) -- China hoped Egypt could restore social stability and normal order at an early date, Foreign Ministry spokesman Hong Lei said Sunday."China has been closely watching the development of the situation in Egypt," Hong said when asked to comment on the ongoing turmoil in the country."Egypt is a friendly country with China, and we hope Egypt could restore social stability and normal order at an early date," he said.

WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.

CHIAYI, Feb. 26 (Xinhua) -- Chen Yunlin, the Chinese mainland chief negotiator with Taiwan, discussed cooperation prospects on Friday with fishermen and farmers in Chiayi in southern Taiwan.Chen, president of the mainland's Association for Relations Across the Taiwan Straits (ARATS), led a 50-member delegation and spoke at a seminar attended by more than 70 business people from both the mainland and Taiwan.He said small and medium-sized enterprises on both sides "played an important role in cross-Strait economic development, employment and in maintaining social stability.""Small- and medium-sized businesses are an important part of cross-Strait economic exchanges," he said, adding that among the more than 80,000 Taiwanese enterprises investing on the mainland, over 50 percent are small and medium-sized companies.Chen said that efforts should be made to enhance cooperation between small and medium-sized enterprises on the mainland and those in central and southern Taiwan.The mainland delegation arrived in Chiayi from Kaohsiung after investigating the investment environment with local business leaders. They arrived in Taipei on Wednesday at the invitation of Chiang Pin-kung, chairman of Taiwan's Straits Exchange Foundation (SEF). Both the SEF and the ARATS are authorized by the two sides to handle cross-Strait affairs.Chen said that since 2005, the mainland bought a large amount of farm and fishing products from Taiwan, which greatly boosted sales of Taiwanese products."Many renowned mainland distribution firms are present here at the seminar to seek cooperation opportunities with Taiwan's farmers and fishermen so that the sale of Taiwanese products on the mainland could increase steadily," he said.Chiang said the farming and fishing industries were the most important sectors in southern Taiwan.He added that the tax-reduction plan of the cross-Strait Economic Cooperation Framework Agreement's (ECFA) "early harvest" program, which took effect on January 1, covered 13 categories for farming products and five categories for fishing goods. Chiang said the plan was an opportunity for the industry to expand its exports to the mainland.He noted that the "early harvest" program's duty exemption also covered sectors like textiles, machinery components, and "all related to small- and medium-sized enterprises."Chiang said Friday's seminar was meant to promote cooperation between smaller businesses across the Strait, to deepen the effect of the ECFA to benefit both sides.The mainland delegation will continue its trip in southern Taiwan and return to Taipei late Saturday. They will visit Taipei's Neihu Industrial Park on Sunday before leaving the island on Monday.

BEIJING, March 21 (Xinhuanet) -- A new device is being developed by American engineers to ease pain of blood sugar testing in diabetics, according to foreign media report last week.The upcoming device is the research target of a team of engineers at Arizona State University. It is specifically designed for patients with type1diabetes and type2 diabetes, according to a report in the "Journal of Diabetes Science and Technology,"  The traditional method of testing blood sugar levels involves painful pricks on the fingers to draw blood for testing. The inconvenient and painful process may somehow leave diabetics lax in their testing. The blood sugar levels, when poorly controlled, are very likely to trigger complications including heart disease, kidney disease and retinopathy.Unlike the old testing method, the new device could help people keep track of their blood sugar levels without the need to break the skin. It draws tears to measures the blood sugar levels in the fluid and gives just an accurate reading of blood sugar levels. "This new technology might encourage patients to check their blood sugars more often, which could lead to better control of their diabetes by a simple touch to the eye." said Jeffrey T. LaBelle, developer of the device.The new testing device has drawn great interest from investors due to its promising prospects. However, it still awaits a significant amount of testing before it can hit the market.

来源：资阳报